Miglustat

Zavesca

Pictures

miglustat gif

Seit Anfang April 2003 steht Miglustat für die orale Behandlung der leichten bis mittelschweren Form des Morbus Gaucher des Typ 1 zur Verfügung Die erbliche Fettstoffwechselstörung

---

dna jpg

GAUCHER DISEASE Canadian Guidelines for Treatment by Enzyme Replacement with Imiglucerase or Substrate Reduction Therapy with Miglustat v 8 March 2007 RevisedGaucherGuidelinesV8Mar26 07 pdf

---

zavesca logo Z motive jpg

Zavesca Zavesca® miglustat is the first and only oral medication indicated for the treatment of mild to moderate type I Gaucher disease Zavesca ® miglustat may be used only in the treatment of

---

zoom jpg

Kadu Cayres O professor Cláudio Lopes coordenador do Laboratório de Síntese e Análise de Produtos Estratégicos LASAPE consultando a última edição do The Merck Index publicação

---

micrmodamiglustatoralcapsule jpg

MIGLUSTAT Oral Capsule

---

StandOrphanet janv2006 sml jpg

http www assises genetique org Nouveaux textes

---

060621 RB courtyard jpg

---

allergies jpg

Mucoviscidose l espoir renaît Selon le professeur Frédéric Becq du Centre National de la Recherche Scientifique CNRS de Poitiers l essai clinique de la molécule miglustat représente un réel espoir pour les

---

1594 jpg

Miglustat is a white to off white crystalline solid and has a bitter taste It is highly soluble in water >1000mg mL as a free base ZAVESCA® is supplied in hard gelatin

---

index png

---

d 4 gif

to the cellular pathology in Gaucher disease remains undefined An illustration demonstrating how cytoplasmic material accumulates in Gaucher and Niemann Pick diseases can be seen in Color Atlas of Hematology 1998 327 Genetics The glucocerebrosidase gene is located on chromosome 1q21 and over 200 mutations associated with Gaucher disease have been identified 7

---

tara02 formel jpg

---

64 27 jpg

misscapuche

---

DRA1 jpg

---

DRA2 jpg

---

clinicaldevelopment2 jpg

---

d 5 gif

The following table summarizes much of the information covered in this case

---

158x123 gyn doctor medical 158x123 gyn doctor medical jpg

---

lab machine jpg

---

o zav1 jpg

Der neue Wirkstoff Miglustat Zavesca® als oraler Inhibitor der Glucosylceramid Synthase stellt ein Gleichgewicht im Glycosphingolipid Metabolismus

---